The Advisory Board Company (ABCO) is Reiterated by FBR Capital to Mkt Perform, Raises Price Target to $ 37

The Advisory Board Company (ABCO) was Reiterated by FBR Capital to “Mkt Perform” according to the research note released today. The brokerage firm has raised the Price Target to $ 37 from a previous price target of $35 . FBR Capital advised their investors in a research report released on Jul 28, 2016.

Many Wall Street Analysts have commented on The Advisory Board Company. The Advisory Board Company was Upgraded by Craig Hallum to ” Buy” on Jul 28, 2016. The Advisory Board Company was Downgraded by Raymond James to ” Mkt Perform” on Jul 19, 2016. The Advisory Board Company was Initiated by Credit Suisse to “Outperform” on Jun 20, 2016.

On the company’s financial health, The Advisory Board Company reported $0.47 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.34. The company had revenue of $198.40 million for the quarter, compared to analysts expectations of $196.49 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.

The Advisory Board Company opened for trading at $45.19 and hit $48.86 on the upside on Thursday, eventually ending the session at $41.46, with a gain of 11.75% or 4.36 points. The heightened volatility saw the trading volume jump to 18,34,599 shares. Company has a market cap of $1,700 M.

In a different news, on Jun 1, 2016, Kelt Kindick (director) purchased 5,000 shares at $32.81 per share price. According to the SEC, on Apr 18, 2016, Cormac F Miller (Chief Product Officer) sold 1,628 shares at $31.65 per share price. On Mar 22, 2016, Hoose Mary Van (Chief Talent Officer) sold 4,172 shares at $30.27 per share price, according to the Form-4 filing with the securities and exchange commission.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

The Advisory Board Company

Leave a Reply

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.